What WARMEN does

WARMEN (贵州威门药业股份有限公司) is a vertically integrated traditional Chinese medicine (TCM) and big-health company founded in 1996 in Guiyang, Guizhou Province, China, and listed on the National Equities Exchange and Quotations (NEEQ) under ticker 430369 since January 2014. The company operates three wholly-owned subsidiaries covering the full industry chain: 兴黔科技 (GAP-standardized cultivation of medicinal herbs), 同威生物 (health products manufacturing using proprietary vacuum freeze-drying technology), and 通和济康医药 (pharmaceutical wholesale and Class I-III medical device distribution). Its core pharmaceutical portfolio spans 21 nationally approved drug varieties (国药准字号) across 6 dosage forms, anchored by the patented flagship 热淋清颗粒 (Re Lin Qing Granules) — an exclusive formulation listed in the national medical insurance catalogue for urinary tract infections that ranks #1 in TCM hospital sales for that indication. Adjacent core products include 金钱胆通颗粒 (cholecystitis/gallstones) and 川芎茶调颗粒 (headache). Beyond pharmaceuticals, the company markets a consumer health line including fresh Dendrobium candidum freeze-dried powder, Gastrodia elata honey tablets, health oral liquids, teas, plant beverages, and a health wine, sold via hospital channels, OTC retail, e-commerce (Warmen Health Mall WeChat/PC), and offline chain stores in an O2O model launched in 2016. The company has accumulated 55 national patents and 200+ government awards, with operations spanning 30+ Chinese provinces plus Hong Kong (2014 entry) and Vietnam (2009 export).

Name

WARMEN

Legal name

贵州威门药业股份有限公司

Website

https://warmen.com

Company type

Public

Founded year

1996

Operating status

Operating

Headcount range

251–500 employees

Short description

WARMEN is a Guiyang-based, NEEQ-listed traditional Chinese medicine and health-products company operating a full industry chain — from proprietary medicinal herb cultivation to patented TCM formulations and consumer health products — serving Chinese hospitals, OTC pharmacies, and e-commerce consumers.

Ownership category

akta.pro rank

Product category

Traditional Chinese Medicine (TCM) Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

akta.pro secondary industries

GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Traditional Chinese medicine
• Pharmaceutical manufacturing
• Health products
• GAP medicinal cultivation
• Freeze-drying technology

Headquarters

HQ city

Guiyang

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. 中成药生产销售: 总公司贵州威门药业股份有限公司重点研发、生产、销售治疗泌尿系统、消化系统等疾病的中成药，涉及6种剂型，现有国药准字号品种21个
2. 保健食品生产销售: 通过子公司贵州同威生物科技有限公司生产铁皮石斛、天麻等系列大健康保健食品
3. 医药流通: 通过子公司贵州通和济康医药有限公司进行药品批发、第一至第三类医疗器械销售
4. 中药材种植: 通过子公司贵州兴黔科技发展有限公司进行头花蓼及铁皮石斛良种繁育和种植

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

WARMEN researches, cultivates, manufactures, and sells Chinese patent medicines (TCM) and health products built on Guizhou-origin medicinal materials. The parent company produces 21 nationally approved TCM drugs across 6 dosage forms, led by the patented Re Lin Qing Granules (热淋清颗粒) for urinary system infections; subsidiaries operate Dendrobium candidum and Gastrodia elata health-product lines and pharmaceutical wholesale distribution. The company operates across the full industry chain from GAP cultivation to manufacturing to multi-channel sales (hospital, OTC, e-commerce, O2O chain stores).

Product overview

WARMEN is a group-oriented pharmaceutical company operating across the full industry chain (primary, secondary, and tertiary industries). The parent company (贵州威门药业股份有限公司) focuses on research, production, and sales of Chinese patent medicines, covering 6 dosage forms with 21 nationally approved drug varieties (国药准字号). Core products include the patented Re Lin Qing Granules (热淋清颗粒) for urinary system infections, Jin Qian Dan Tong Granules (金钱胆通颗粒) for gallbladder conditions, and Chuan Xiong Cha Tiao Granules (川芎茶调颗粒) for headaches. Subsidiary 贵州同威生物科技有限公司 operates the Tianma and Dendrobium candidum big health product chains, offering 8 Tianma products (freeze-dried powder, honey tablets, pure powder tablets, cell wall-broken slices, walnut drink) and 6 Dendrobium candidum products (freeze-dried powder, freeze-dried flowers, cun jin, granules, oral liquid). Subsidiary 贵州兴黔科技发展有限公司 manages GAP-standardized cultivation bases for Polygonum capitatum and Dendrobium candidum as raw material supply. Subsidiary 贵州通和济康医药有限公司 handles pharmaceutical wholesale and medical device distribution. The company also operates the Warmen Health E-commerce Platform (威门大健康商城) combining online WeChat/PC mall with offline chain stores for O2O integrated sales.

Differentiator

Problem solved

Functional benefit

Brands

• 威门大健康商城: O2O健康医药平台,提供线上线下联动的大健康产品销售服务
• 威门堂
• 威门石斛水
• 铁西牛
• 铁蝙青
• 麻花茶

Products and services

• Re Lin Qing Granules (热淋清颗粒) Patented Chinese medicine preparation for treating urinary system infections; the company's flagship product, national medical insurance exclusive formulation, and #1 ranked product in Chinese urology-TCM hospital sales.
• Jin Qian Dan Tong Granules (金钱胆通颗粒) A patented Chinese medicine for treating acute and chronic cholecystitis, gallstones, and post-operative syndrome; national medical insurance and national essential medicine formulation.
• Chuan Xiong Cha Tiao Granules (川芎茶调颗粒) A national essential medicine for treating headaches and improving cerebral blood and oxygen supply; also available in a sugar-free formulation.
• Zhong Jie Feng Dispersible Tablets (肿节风分散片) A dispersible tablet form of Chinese herbal medicine, listed as a traditional Chinese medicine product.
• Dang Gui Tiao Jing Granules (当归调经颗粒) A granule preparation for regulating menstruation, containing Danggui (Angelica sinensis) as a key ingredient; available in sugar-free formulation.
• Warmen Dendrobium Water (威门石斛水) A plant-based beverage made from Dendrobium candidum leaves, positioned as a health drink in the big health product line.
• Fresh Dendrobium Candidum Powder (鲜铁皮石斛粉) Fresh Dendrobium candidum processed into powder form using freeze-drying technology to preserve active ingredients; direct oral Chinese medicine decoction piece.
• Tie Xi Niu Oral Liquid (铁西牛 / 威门牌铁皮石斛西洋参牛磺酸口服液) A health oral liquid combining Dendrobium candidum, American ginseng, and taurine, designed for immunity enhancement and fatigue relief.
• Tie Bian Qing Granules (铁蝙青 / 威门牌铁皮石斛蝙蝠蛾拟青霉颗粒) A health granule product combining Dendrobium candidum with Cordyceps sinensis-like fungus (蝙蝠蛾拟青霉) for immunity enhancement and wellness purposes.
• Ma Hua Tea (麻花茶 / 威门牌罗布麻叶杜仲叶天麻槐花菊花绿茶袋泡茶) A bag-brewing tea containing Apocynum venetum leaves, Eucommia leaves, Gastrodia elata, Sophora flower, chrysanthemum, and green tea.
• Shen Mi 7.5 Liquor (神秘7.5酒) A health-targeted alcoholic beverage in the company's big health product portfolio.
• Gastrodia Elata Health Product Series (贵天麻养生保健系列) A sub-brand under Tongwei Bio including 8 product series: fresh Gastrodia elata freeze-dried powder, Gastrodia elata honey tablets, pure powder direct-press tablets, cell wall-broken slices, walnut drink, and more.
• Dendrobium Candidum Health Product Series (铁皮石斛养生保健食品系列) A sub-brand under Tongwei Bio including 6 product series: fresh Dendrobium candidum freeze-dried powder, freeze-dried flowers, cun jin, granules, and oral liquid.
• Warmen Health E-commerce Platform (威门大健康电商平台) An online-to-offline (O2O) health e-commerce platform integrating WeChat mall, PC mall, and offline chain stores for integrated online-offline sales of health products and TCM products.
• Polygonum Capitatum GAP Cultivation Base (头花蓼GAP种植基地) Good Agricultural Practice standardized cultivation base for Polygonum capitatum (头花蓼), the key medicinal raw material for Re Lin Qing Granules, operated by subsidiary Guizhou Xingqian Technology Development Co., Ltd.
• Dendrobium Candidum GAP Cultivation Base (铁皮石斛GAP种植基地) GAP-standardized Dendrobium candidum cultivation base providing raw materials for the subsidiary Tongwei Bio's health product series, operated by Guizhou Xingqian Technology Development Co., Ltd.
• Pharmaceutical Wholesale and Medical Device Distribution Pharmaceutical wholesale and Class I-III medical device sales operated by subsidiary Guizhou Tonghe Jikang Pharmaceutical Co., Ltd. with GSP certification.

Quantifiable outcome

• 热淋清颗粒在全国泌尿系统感染中成药医院销量排名第一
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core.

• 大方县coreStrategic or Co-development Partner · 12 July 2017与大方县合作进行贵天麻良种繁育基地建设，响应农工党中央支持毕节试验区建设号召
• 贵州中医药大学coreStrategic or Co-development Partner与贵州中医药大学合作进行苗药头花蓼深入系统研究与产业化开发关键技术推广应用，获得贵州省科学技术进步奖一等奖
• 中药固体制剂制造技术国家工程研究中心coreStrategic or Co-development Partner联合国家级科研机构进行真空冷冻干燥技术研发，研制出鲜铁皮石斛粉和鲜天麻粉
• 中药固体制剂制造技术国家工程研究中心coreTechnology or Integration联合国家级科研机构进行冻干技术研发

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Broad incumbents

• Yunnan Baiyao Group (云南白药): Iconic national TCM brand with strong OTC and consumer-health presence; serves as the dominant scaled comparable for Warmen's brand-TCM and 大健康 ambitions.
• Hutchison China MediTech (Chi-Med, 黄医药): Larger Chinese pharma combining TCM heritage with innovative-drug pipeline; illustrative of the capital-markets path from NEEQ/small-cap TCM to broader investor base.
• China Resources Sanjiu Medical & Pharmaceutical (华润三九): Major OTC TCM platform with national chain coverage; provides benchmark for Warmen's hospital-to-OTC brand migration and O2O chain-store model.
• Guangzhou Baiyunshan Pharmaceutical (白云山): Large state-affiliated TCM, chemical drug and health-products manufacturer; representative peer for Warmen's full industry-chain (cultivation–manufacturing–distribution) play at scaled benchmark.
• Pien Tze Huang (片仔癀): High-margin specialty TCM franchise with national insurance coverage and a herbal raw-material moat; relevant comparable for Warmen's national-insurance-protected Re Lin Qing Granules.
• China Tongrentang (同仁堂): Premier Chinese patent medicine incumbent with hundreds of 国药准字 approvals and a national chain-store footprint; useful benchmark for Warmen's brand TCM and O2O channel strategy.

Direct peers

• Jilin Aodong Pharmaceutical (吉林敖东): Mid-cap TCM and chemical drug manufacturer listed on Shenzhen Main Board with comparable product breadth, hospital-channel focus, and regional-resource-driven supply chain.
• Zhejiang Conba Pharmaceutical (康恩贝): Comparable mid-cap TCM and plant-based healthcare products manufacturer with overlapping botanical/中药材 cultivation and OTC channels; shares Warmen's brand TCM + health-products dual model.
• Guizhou Yibai Pharmaceutical (贵州益佰制药): Guizhou-based, mid-cap Chinese patent medicine manufacturer with a comparable portfolio of TCM injections and oncology/urinary/cardiovascular franchises. Closest geographic and product-mix peer to Warmen.
• Shanghai Kaibao Pharmaceutical (上海凯宝制药): Similar-size Chinese patent medicine manufacturer focused on respiratory and infectious-disease indications (痰热清注射液), sharing the 'narrow-but-leading-hospital-franchise' profile with Warmen.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WARMEN